CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

โŒ•
Regions
Topics
Saved views:
Save your current filters to revisit or share.
6 stories
๐Ÿ‡ต๐Ÿ‡ฑ Rzeczpospolita
Life & Tech

The breakthrough that ADHD patients have been waiting for? A new drug is already waiting for approval. Psychiatrist comments

A new ADHD drug called centanafadine is awaiting FDA approval and presents potential changes in treatment options.

Feb 26 โ€ข 10:04 UTC
๐Ÿ‡ฎ๐Ÿ‡น Il Giornale
National & Local

Pancreatic cancer, with this drug a decisive turning point approaches: the approval of Aifa

A new drug, Olaparib, is set to be approved for the treatment of metastatic pancreatic cancer, marking a significant advance in the battle against this deadly disease.

Feb 23 โ€ข 12:29 UTC
๐Ÿ‡ง๐Ÿ‡ท G1 (PT)
Crime & Justice

The PCC chief sentenced to 126 years who left prison through the front door with the approval of a retired judge

Gerson Palermo, a leader of the First Command of the Capital (PCC), was sentenced to 126 years in prison but was released from a maximum-security facility with the approval of a retired judge, raising concerns over judicial processes.

Feb 11 โ€ข 20:48 UTC
๐Ÿ‡ฒ๐Ÿ‡ฝ El Financiero (ES)
Crime & Justice

Tequila, a turning point

The mayor of Tequila, Diego Rivera Navarro, has been imprisoned due to serious missteps involving his approval of a concert promoting a notorious drug lord and being accused of extortion.

Feb 10 โ€ข 07:00 UTC
๐Ÿ‡ฌ๐Ÿ‡ท Proto Thema
National & Local

The Academy of Rare Patients Greece has started: Its members will participate in the development and approval of drugs

The newly established Academy of Rare Patients in Greece aims to train its members to actively participate in the evaluation and approval processes of medical treatments at both European and international levels.

Feb 7 โ€ข 11:46 UTC
๐Ÿ‡ฆ๐Ÿ‡ท Clarin (ES)
Life & Tech

How the drugs that will revolutionize obesity treatment work

Semaglutide by Novo Nordisk is the first drug approved for obesity treatment that achieves weight loss comparable to bariatric surgery, while Eli Lilly's tirzepatide is expected to gain approval soon after showing efficacy and safety in clinical trials.

Feb 5 โ€ข 10:01 UTC

Story in context

Loading Intelligence...

๐Ÿ“ก

Select a report from the feed to view analysis and related coverage.